These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 2236899)

  • 1. Plasma calcitonin levels in patients with cystic fibrosis.
    Sagulin GB; Bucht E; Gilljam H; Sjöberg H; Roomans GM
    Res Commun Chem Pathol Pharmacol; 1990 Sep; 69(3):325-34. PubMed ID: 2236899
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Calcitonin levels in normal subjects according to age and sex.
    Loré F; Galli M; Franci B; Martorelli MT
    Biomed Pharmacother; 1984; 38(5):261-3. PubMed ID: 6525423
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum CA 19-9 levels as a diagnostic marker in cystic fibrosis patients with borderline sweat tests.
    Augarten A; Berman H; Aviram M; Diver-Habber A; Akons H; Ben Tur L; Blau H; Kerem E; Rivlin J; Katznelson D; Szeinberg A; Kerem BS; Theodor L; Paret G; Yahav Y
    Clin Exp Med; 2003 Sep; 3(2):119-23. PubMed ID: 14598187
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Normal adiponectin levels despite abnormal glucose tolerance (or diabetes) and inflammation in adult patients with cystic fibrosis.
    Hammana I; Malet A; Costa M; Brochiero E; Berthiaume Y; Potvin S; Chiasson JL; Coderre L; Rabasa-Lhoret R
    Diabetes Metab; 2007 Jun; 33(3):213-9. PubMed ID: 17418606
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Vitamin E deficiency in cystic fibrosis].
    Muñoz C; Polanco I; Hernanz A; Carrasco S; Barea I; Murga ML; Arroba ML; Codoceo R
    An Esp Pediatr; 1987 Dec; 27(6):445-8. PubMed ID: 3447496
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The regulation of calcitonin in normal human plasma as assessed by immunoprecipitation and immunoextraction.
    Parthemore JG; Deftos LJ; Bronzert D
    J Clin Invest; 1975 Oct; 56(4):835-41. PubMed ID: 808561
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum bile acids and ursodeoxycholic acid treatment in cystic fibrosis-related liver disease.
    O'Brien SM; Campbell GR; Burke AF; Maguire OC; Rowlands BJ; FitzGerald MX; Hegarty JE
    Eur J Gastroenterol Hepatol; 1996 May; 8(5):477-83. PubMed ID: 8804877
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decrease in insulin and insulin-like growth factor I (IGF-I) binding to erythrocytes from patients with cystic fibrosis.
    Dooghe C; Grizard G; Labbe A; Grigorescu F; Dardevet D; Grizard J
    Diabetes Metab; 1997 Dec; 23(6):511-8. PubMed ID: 9496557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased soluble CD40 ligand levels in cystic fibrosis.
    Falco A; Romano M; Iapichino L; Collura M; Davì G
    J Thromb Haemost; 2004 Apr; 2(4):557-60. PubMed ID: 15102009
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low levels of pyridoxal 5'-phosphate in patients with cystic fibrosis.
    Faraj BA; Caplan DB; Camp VM; Pilzer E; Kutner M
    Pediatrics; 1986 Aug; 78(2):278-82. PubMed ID: 3737304
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Copper and zinc levels in nails of children with cystic fibrosis, carriers and healthy controls (author's transl)].
    Escobar H; Arroyo M; Suárez L; Camarero C; Crespo E; Vera C
    An Esp Pediatr; 1980 Feb; 13(2):127-32. PubMed ID: 7396268
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased plasma levels of adrenomedullin, a vasoactive peptide, in patients with end-stage pulmonary disease.
    Vizza CD; Letizia C; Sciomer S; Naeije R; Della Rocca G; Di Roma A; Musarò S; Quattrucci S; Gaudio C; Battagliese A; Badagliacca R; D'Erasmo E; Fedele F
    Regul Pept; 2005 Jan; 124(1-3):187-93. PubMed ID: 15544858
    [TBL] [Abstract][Full Text] [Related]  

  • 13. alpha-Fetoprotein and cystic fibrosis.
    Beaudry PH; Bergsteinsson H; Dupont C; Wong HC; Shuster J; Desmond K; Gold P
    Clin Invest Med; 1982; 5(1):45-7. PubMed ID: 6180858
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Depressed plasma retinol-binding protein levels in cystic fibrosis.
    Smith FR; Underwood BA; Denning CR; Varma A; Goodman DS
    J Lab Clin Med; 1972 Sep; 80(3):423-33. PubMed ID: 5055389
    [No Abstract]   [Full Text] [Related]  

  • 15. Plasma and red blood cell zinc in cystic fibrosis.
    Akanli L; Lowenthal DB; Gjonaj S; Dozor AJ
    Pediatr Pulmonol; 2003 Jan; 35(1):2-7. PubMed ID: 12461732
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypovitaminosis D and response to supplementation in older patients with cystic fibrosis.
    Hanly JG; McKenna MJ; Quigley C; Freaney R; Muldowney FP; FitzGerald MX
    Q J Med; 1985 Jul; 56(219):377-85. PubMed ID: 4095249
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pancreatitis among patients with cystic fibrosis: correlation with pancreatic status and genotype.
    De Boeck K; Weren M; Proesmans M; Kerem E
    Pediatrics; 2005 Apr; 115(4):e463-9. PubMed ID: 15772171
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adult cystic fibrosis: postprandial response of gut regulatory peptides.
    Allen JM; Penketh AR; Adrian TE; Lee YC; Sarson DL; Hodson ME; Batten JC; Bloom SR
    Gastroenterology; 1983 Dec; 85(6):1379-83. PubMed ID: 6628932
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Scotopic thresholds and plasma retinol in cystic fibrosis.
    Fulton AB; Hansen RM; Underwood BA; Shwachman H; Barg DC
    Invest Ophthalmol Vis Sci; 1982 Sep; 23(3):364-70. PubMed ID: 7107162
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum immunoreactive pancreatic lipase and cationic trypsinogen for the assessment of exocrine pancreatic function in older patients with cystic fibrosis.
    Cleghorn G; Benjamin L; Corey M; Forstner G; Dati F; Durie P
    Pediatrics; 1986 Mar; 77(3):301-6. PubMed ID: 3951910
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.